Advanced Search


Study ID Status Title Patient Level Data
201109 Terminated WEUSKOP7134: PASS HCV Research UK: Prospective observational cohort study to explore the safety and effectiveness of eltrombopag in a real-world setting in adult patients with chronic hepatitis C virus infection who are unable to initiate or maintain optimal interferon-based therapy due to thrombocytopenia nested within the HCV Research UK National Registry
201114 Active, Not Recruiting Reasons for discontinuation of injectable diabetes medications: wave 2
201120 Completed A Phase IIa Study to Evaluate the Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
201121 Not yet recruiting Epidemiological study assessing the Burden of Illness related to COPD exacerbations in Québec
201131 Completed A randomised, double-blind, study to investigate the effects of creatine supplementation on muscle energetics and cognitive function in young healthy male athletes and an ageing population using phosphorus-31 magnetic resonance spectroscopy (31P MRS) and functional magnetic resonance imaging (fMRI)
201135 Completed 201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down from a Maintenance Therapy with RELVAR® inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects Study Listed on
201147 Completed 201147: a Phase IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose combination of abacavir/dolutegravir/ lamivudine from current antiretroviral regimen compared with continuation of the current antiretroviral regimen in HIV-1 infected adults who are virologically suppressed, The STRIIVING Study.
201152 Active, Not Recruiting Indirect treatment comparisons of Ph3 combination studies for dabrafenib plus trametinib versus other treatments
201153 Completed Updated analyses adjusting for treatment crossover in Part C of a Phase 2 trial (BRF113220) of dabrafenib and trametinib combination therapy in patients with metastatic melanoma based on recent dataset (March 2013)
201159 Completed A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis
201167 Completed A Phase I, open label, parallel group, three period, fixed sequence crossover study to evaluate the effect of dolutegravir on metformin pharmacokinetics in healthy adult subjects
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201186 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2011-2012
201188 Completed PGx7529: Exploratory Pharmacogenetic evaluation of Potential Modifiers of Duchenne Muscular Dystrophy patient response to Drisapersen
201211 Completed A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD Study Listed on
201216 Active, Not Recruiting PGx7521: Evaluation of validated HLA markers with DILI in lapatinib clinical trial EGF106903
201223 Active, Not Recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201224 Completed Meta-Analysis Plan for GSK1550188, 201224, Concomitant Medications Analysis
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201234 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) compared to Fluzone® Quadrivalent in children 6 to 35 months of age Study Listed on
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201240 Completed Waterpipe use in the Middle East and North Africa: analysis of the BREATHE study
201243 Completed Distribution of body mass index among subjects with chronic obstructive pulmonary disease in the Middle East and North Africa: data from the BREATHE study
201244 Completed A randomized, double-blinded study to evaluate the ability of an acne treatment product to produce visible improvements in acne lesions over a 5 day period of once-daily use



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.